Investment
Features
FeesSafety
Academy
More
Pluang+

Compare ADMA Biologics Inc (ADMA) vs Eli Lilly And Co (LLY) Price & Performance

ADMA Biologics IncTrade
Eli Lilly And CoTrade

Price performance (Past 24H)

Key statistics

ADMA Biologics Inc vs Eli Lilly And Co — how do they compare? ADMA Biologics Inc trades at $9.81 (market cap $2.22B), while Eli Lilly And Co trades at $1,212 (market cap $1.08T). The key difference: Eli Lilly And Co is far larger — about 486.5× ADMA Biologics Inc's market cap, and Eli Lilly And Co pays a 0.57% dividend while ADMA Biologics Inc pays none. Which is the better fit depends on your goals.

ADMALLY
Market Cap
$2.22B$1.08T
Sector
HealthHealth
52-Week High
$20.38$1.24K
52-Week Low
$7.60$639.43
Enterprise Value
$2.29B$1.13T
Dividend Yield
0.57%

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About ADMA Biologics Inc

ADMA Biologics is a biopharmaceutical company specializing in plasma-derived therapies for immunodeficient patients. Key products like ASCENIV and BIVIGAM treat primary humoral immunodeficiency and help prevent infectious diseases.

Read more on ADMA

About Eli Lilly And Co

Eli Lilly is a drug firm with a focus on neuroscience, endocrinology, cancer, and immunology. Lilly's key products include Verzenio for cancer

Read more on LLY